Proton Therapy Treatment Center Agreement Reached by Delray Medical Center, Proton International

DELRAY BEACH, Fla.–(BUSINESS WIRE)–#cancer–Delray Medical Center (www.delraymedicalctr.com)
has reached agreement with Proton International (PI) (www.protonintl.com)
to build a one-room proton therapy treatment center serving the South
Florida corridor. Proton therapy, a form of radiation therapy, is a
highly precise and effective treatment for many cancer tumors but
without many of the side effects that often accompany treatment.

Delray will be among a select group of hospitals in the country to offer
proton therapy using the most advanced technology available, a fully
featured compact system with dynamic peak pencil beam scanning,
developed by Varian Medical Systems.

“We are looking forward to offering this innovative treatment option at
Delray Medical Center,” said Mark Bryan, CEO. “It is always our goal to
incorporate new technologies and techniques that will make treatment
safer and less invasive for our patients.”

“We are very pleased to team with Delray to assure broader access to
this important cancer therapy. It will allow people to be treated in
their community, close to family and friends,” said Chris Chandler, CEO
of Proton International, which currently has proton centers under
construction at Beaumont Hospital, Royal Oak, Mich., and the University
Medical Center in Groningen, The Netherlands. “We selected Varian to be
the proton system provider because Varian’s ProBeam system has unique
capabilities making it the most complete single room proton system on
the market.”

Proton therapy is particularly effective in treating solid cancer
tumors, including tumors of the brain, spine, head and neck, lung,
prostate, colon, and some breast tumors. It is widely used to treat
children with cancer because of its precision and lack of long-term side
effects, as children are particularly sensitive to the effects of
radiation therapy.

Pencil Beam Scanning gives physicians advanced options for delivering
proton therapy precisely in order to minimize exposure to healthy tissue
while delivering treatments. The scanning beam technology enables
“intensity-modulated proton therapy” (IMPT) by adjusting dose levels on
a spot-by-spot basis throughout the treatment area.

PI’s turnkey development significantly lowers project risk and provides
access to long-term funding, making it easier and more affordable for
hospitals, oncologists and other medical professionals to offer proton
cancer therapy to patients in one- or two-room centers.

Contacts

Proton International
Kristen Chandler, 502-939-3323
kchandler@protonintl.com